Gossamer Bio, Inc. — Director's Dealing 2020

Jun 23, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2020-06-23

Reporting Person: Giraudo Bryan (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-23	Common Stock	P	2000	$12.9612	Acquired	4121	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70379	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $12.9606 to $12.962 per share. The price reported above reflects the weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price can be obtained from the Issuer upon request.

F2: Includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date.